A new ultra-low-dose combination oral contraceptive
Related Experiment Videos
The Journal of Reproductive Medicine
|January 1, 1983
Abstract:
Data were compiled from 17 U.S. sites during a study of levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. A total of 1,130 women participated in 11,604 cycles of treatment. Efficacy, cycle characteristics, bleeding irregularities and side effects were studied. Weight and blood pressure means were analyzed with the paired t-test. Subject acceptance of this new combination oral contraceptive was high.
Keywords:
Acceptor CharacteristicsAcceptorsContraceptionContraception TerminationContraceptive AgentsContraceptive Agents, FemaleContraceptive Methods--pharmacodynamicsContraceptive Methods--side effectsFamily PlanningFamily Planning ProgramsMenstrual CycleMenstruationOral Contraceptives, CombinedOral Contraceptives, Low-doseOral Contraceptives--pharmacodynamicsOral Contraceptives--side effectsReproductionReproductive Control Agents